FEATURED ARTICLES
The Rise — And Stall — Of Retail Pharmacy Clinical Trials
As rumors swirl that Walgreens may be reassessing its clinical trials business, this article explores a broader trend: why major retail pharmacy chains like CVS, Walmart, and Kroger have struggled to make the model work at scale.
-
Slot Allocation Is A Problem For Patients And PIs In Phase 1 Oncology Trials (Part 1)
Given the shift in the size and scope of oncology Phase 1 trials, cohort management and slot allocation strategies must change, too. Nehal Lakhani, MD, Ph.D. explains why competitive slot allocation is no longer optimal for patients or PIs.
-
Considerations For Allergic Rhinitis Trials Are Nothing To Sneeze At
Inimmune CEO David Burkhart explains how a GSK layoff led to the formation of a new company focused on treating allergic rhinitis. Here, he shares success from the company's approach to site selection, trial design, and timing.
-
Could Study Rehearsals Create A New Standard For Site Readiness?
Giving sites the chance to rehearse a trial ahead of their initial study visits could lead to improved readiness, protocol adherence, and participant experience.